Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards in the Innovation category for its eClinical Platform.
The Clinical Trials Arena Excellence Awards celebrate the greatest achievements and innovations in the industry. Powered by GlobalData’s business intelligence, the program recognizes the people and companies that are driving change.
Clinion won the Innovation award for integrating artificial intelligence (AI) and machine learning (ML) into its electronic data capture (EDC) platform, significantly enhancing efficiency and data quality in clinical trials. The award also recognizes Clinion’s comprehensive suite of complementary products and innovative features like real-time protocol amendments and extensive API integrations, which collectively streamline the entire clinical trial process.
AI, ML and GenAI integration in clinical trials platform
Clinion has boldly integrated AI, ML and generative AI (GenAI) into its platform, introducing advanced features such as AI Medical Coding, which simplifies the complex process of categorizing medical terms, eProtocol Generation, CDASH coding, Remote Source Data Verification, CSR Automation and Conversational Bots including GenAI capabilities for advanced reporting. These innovations not only boost efficiency but also significantly improve data quality, ensuring that clinical trials are both accurate and cost-effective.
By investing in complementary products like Randomization and Trial Supply Management (RTSM), Clinical Trial Management System (CTMS), Electronic Patient-Reported Outcomes (ePRO), eConsent, and Document Automation, Clinion has crafted a unified eClinical platform. The holistic approach enabled to offer a one-stop-shop experience that eliminates the need for disparate systems, thereby reducing complexity and enhancing the user experience.
Streamlined data management and real-time amendments
The innovative Data Loader feature for bulk data import is a game-changer, allowing for the swift and efficient transfer of large datasets into the Clinion EDC system. The platform’s robust support for medical coding, complete with synonym management and up-versioning, ensures that data remains consistent and up-to-date—a critical factor in the success of any clinical trial.
Clinion EDC’s capability to manage protocol amendments in real time with zero downtime is significant too. This feature allows for seamless updates to ongoing trials without any interruption, ensuring that research can continue without costly delays. It demonstrates Clinion’s dedication to providing solutions that are not only innovative but also responsive to the real-world needs of clinical research.
Extensive integration and user-centric design
Clinion EDC’s extensive API integrations with lab systems, eCOAs, eDiaries, and CTMS, such as Clinion CTMS, are a testament to the platform’s flexibility and its ability to adapt to a variety of research environments. Furthermore, the platform’s support for multi-language forms and surveys is crucial for global trials, ensuring inclusivity and accessibility for diverse patient populations across different geographies.
The user experience is enhanced by features like a drag-and-drop form/survey designer, standardized global libraries and single sign-on, which streamline the setup and management of clinical trials. The system’s data management capabilities, including on-demand data extraction, data archiving, and study-level encryption, ensure the security and robustness of the system.
Reporting, visualization, and compliance
Clinion EDC offers a range of out-of-the-box reports and ad-hoc report creation capabilities, enabling better decision-making and oversight for clinical trial managers. The platform’s compliance with industry data standards and regulations, such as Health Insurance Portability and Accountability Act (HIPAA) and Clinical Data Interchange Standards Consortium (CDISC), underscores its commitment to data governance and security.
Clinion’s strategic investments in AI and ML, its comprehensive integrated platform, and user-centric features like the Data Loader and real-time protocol amendments have revolutionized the way clinical trials are conducted. With extensive API integrations, multilingual support, and a focus on user experience and data management, Clinion EDC helps bring life-saving treatments to market faster and more efficiently.
“AI and GenAI is rapidly moving from hype to reality in clinical research and has the potential to reduce trial costs and timelines by as much as 30%.” – Manuj Vangipurapu, CEO, Clinion
Company Profile
Clinion is a leading global clinical trial company renowned for its award-winning solutions that drive innovation and excellence in the field of clinical research. We implement cutting-edge technologies like AI/ML and GenAI to accelerate clinical trials for better outcomes. The clinical trial solutions that we offer include AI-powered EDC, CTMS, RTSM, eTMF, ePRO, eConsent, Document Automation and AI Medical Coding.Â
Our unparalleled expertise empowers pharmaceutical, biotechnology, and medical device companies to conduct clinical trials more efficiently and effectively. Join us in revolutionizing the future of clinical trials and making a lasting impact on global healthcare.
Contact DetailsÂ
Clinion Inc.
5900 Balcones Drive, STE 100,
Austin, TX 78731,
United States
Phone: +91 7337382327
E-mail: sales@clinion.com
Links
Website: https://www.clinion.com/
